Target intelligence / Profile preview

Nuclear receptor subfamily 6 group A member 1 (NR6A1)

Target
NR6A1
Molecular classification
Receptor, Nuclear receptor, Transcription factor
01

Overview

Nuclear receptor subfamily 6 group A member 1 (NR6A1), also known as Germ cell nuclear factor (GCNF), is a transcriptional repressor belonging to the nuclear receptor superfamily. NR6A1 is expressed predominantly in germ cells and plays an essential role in embryogenesis, germ cell differentiation, and the regulation of pluripotency and developmental timing, particularly in body axis and vertebral development. Its principal function is to repress gene expression by binding specific DNA sequences as a homodimer and recruiting corepressors or modulating histone methylation and acetylation. NR6A1 tightly regulates Hox gene clusters, thus influencing segmentation and morphogenesis of the vertebrate trunk during development. Alterations in NR6A1 function are implicated in defects of vertebral segmentation and possibly in cancer and other developmental disorders. No direct drugs or biomarkers are established for this target; it is not currently a validated therapeutic target in clinical use but is of significant biological interest in developmental and reproductive biology[1][2][3].

Other names
Germ cell nuclear factorGCNFRTRhGCNFhRTRGCNF1CT150retinoid receptor-related testis-specific receptorretinoic acid receptor-related testis-associated receptor
02

Mechanism of action

Transcriptional repression (repressor binding to DNA and recruiting corepressors/histone modification proteins, e.g., methyl transferases, Nuclear receptor corepressor 1 (Ncor1), Ubiquitin interacting motif containing 1 (UIMC1))

03

Biological functions

Regulation of transcriptionGerm cell differentiationEmbryogenesisRegulation of pluripotencyRegulation of Hox gene expressionMesenchymal stem cell differentiationRepression of gene expressionDevelopmental timing (axis/trunk formation)
04

Disease associations

Cancer (evidence of involvement in gene repression in germ cells and embryogenesis, which may be relevant in cancer)Other (developmental disorders related to axis or vertebral segmentation, based on mouse models)
05

Safety considerations

Potential developmental toxicity if targetedimpact on germ cell and embryonic developmentrisk of off-target effects on trunk/tail formation or neurogenesis

Beyond the preview

Go deeper on Nuclear receptor subfamily 6 group A member 1 (NR6A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear receptor subfamily 6 group A member 1 (NR6A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call